(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Theseus Pharmaceuticals, Inc. Insider Trading
* In original currency USD
Loading Data
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Wednesday, February 14th, 2024 | Yi Kathy | director | 0 | D-Return | D | 3,250 | 0.00 USD | 0 USD |
| Wednesday, February 14th, 2024 | Yi Kathy | director | 0 | D-Return | D | 99,634 | 4.03 USD | 401,993 USD |
| Wednesday, February 14th, 2024 | Stein Steven H | director | 0 | D-Return | D | 3,250 | 0.00 USD | 0 USD |
| Wednesday, February 14th, 2024 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 0 | U-Tender | D | 650,600 | 4.05 USD | 2,634,930 USD |
| Wednesday, February 14th, 2024 | HAYDEN DONALD J JR | director | 0 | U-Tender | D | 10,000 | 4.05 USD | 40,500 USD |
| Wednesday, February 14th, 2024 | HAYDEN DONALD J JR | director | 0 | D-Return | D | 3,250 | 0.00 USD | 0 USD |
| Wednesday, February 14th, 2024 | GORDON CARL L | director, 10 percent owner: | 0 | U-Tender | D | 650,600 | 4.05 USD | 2,634,930 USD |
| Wednesday, February 14th, 2024 | GORDON CARL L | director, 10 percent owner: | 0 | D-Return | D | 3,250 | 0.00 USD | 0 USD |
| Wednesday, February 14th, 2024 | Dukes Iain D. | director | 0 | U-Tender | D | 388,324 | 4.05 USD | 1,572,712 USD |
| Wednesday, February 14th, 2024 | Dukes Iain D. | director | 0 | D-Return | D | 3,250 | 0.00 USD | 0 USD |
| Wednesday, February 14th, 2024 | Dukes Iain D. | director | 0 | D-Return | D | 344,344 | 0.32 USD | 109,329 USD |
| Wednesday, February 14th, 2024 | Dukes Iain D. | director | 0 | D-Return | D | 61,549 | 4.03 USD | 248,332 USD |
| Wednesday, February 14th, 2024 | Dahms Bradford D. | officer: President and CFO | 0 | U-Tender | D | 8,150.225 | 4.05 USD | 33,008 USD |
| Wednesday, February 14th, 2024 | Dahms Bradford D. | officer: President and CFO | 0 | D-Return | D | 17,500 | 0.00 USD | 0 USD |
| Wednesday, February 14th, 2024 | Dahms Bradford D. | officer: President and CFO | 0 | D-Return | D | 332,114 | 4.03 USD | 1,339,980 USD |
| Monday, November 6th, 2023 | Shakespeare William | officer: See Remarks | 639,408 | M-Exempt | A | 251,084 | 0.32 USD | 80,347 USD |
| Monday, November 6th, 2023 | Shakespeare William | officer: See Remarks | 93,260 | M-Exempt | D | 251,084 | 0.32 USD | 80,347 USD |
| Monday, July 17th, 2023 | GORDON CARL L | director, 10 percent owner: | 17,063,000 | P-Purchase | A | 328,482 | 3.05 USD | 1,001,870 USD |
| Monday, July 17th, 2023 | GORDON CARL L | director, 10 percent owner: | 650,600 | P-Purchase | A | 151,450 | 3.05 USD | 461,922 USD |
| Monday, July 17th, 2023 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 17,063,000 | P-Purchase | A | 328,482 | 3.05 USD | 1,001,870 USD |
| Monday, July 17th, 2023 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 650,600 | P-Purchase | A | 151,450 | 3.05 USD | 461,922 USD |
| Monday, July 17th, 2023 | Foresite Capital Management V, LLC | 10 percent owner | 4,108,796 | P-Purchase | A | 523,450 | 2.97 USD | 1,554,646 USD |
| Monday, July 17th, 2023 | Foresite Capital Management V, LLC | 10 percent owner | 1,385,825 | P-Purchase | A | 176,550 | 2.97 USD | 524,354 USD |
| Tuesday, June 13th, 2023 | Stein Steven H | director | 19,500 | A-Award | A | 19,500 | 9.61 USD | 187,395 USD |
| Tuesday, June 13th, 2023 | Stein Steven H | director | 3,250 | A-Award | A | 3,250 | 0.00 USD | 0 USD |
| Tuesday, June 13th, 2023 | Yi Kathy | director | 19,500 | A-Award | A | 19,500 | 9.61 USD | 187,395 USD |
| Tuesday, June 13th, 2023 | Yi Kathy | director | 3,250 | A-Award | A | 3,250 | 0.00 USD | 0 USD |
| Tuesday, June 13th, 2023 | HAYDEN DONALD J JR | director | 19,500 | A-Award | A | 19,500 | 9.61 USD | 187,395 USD |
| Tuesday, June 13th, 2023 | HAYDEN DONALD J JR | director | 3,250 | A-Award | A | 3,250 | 0.00 USD | 0 USD |
| Tuesday, June 13th, 2023 | GORDON CARL L | director, 10 percent owner: | 19,500 | A-Award | A | 19,500 | 9.61 USD | 187,395 USD |
| Tuesday, June 13th, 2023 | GORDON CARL L | director, 10 percent owner: | 3,250 | A-Award | A | 3,250 | 0.00 USD | 0 USD |
| Tuesday, June 13th, 2023 | Dukes Iain D. | director | 19,500 | A-Award | A | 19,500 | 9.61 USD | 187,395 USD |
| Tuesday, June 13th, 2023 | Dukes Iain D. | director | 3,250 | A-Award | A | 3,250 | 0.00 USD | 0 USD |
| Wednesday, March 1st, 2023 | Rivera Victor | officer: Chief Scientific Officer | 16,250 | A-Award | A | 16,250 | 0.00 USD | 0 USD |
| Wednesday, March 1st, 2023 | Shakespeare William | officer: See Remarks | 21,250 | A-Award | A | 21,250 | 0.00 USD | 0 USD |
| Wednesday, March 1st, 2023 | Kerstein David | officer: Chief Medical Officer | 17,500 | A-Award | A | 17,500 | 0.00 USD | 0 USD |
| Wednesday, March 1st, 2023 | Dahms Bradford D. | officer: Chief Financial Officer | 17,500 | A-Award | A | 17,500 | 0.00 USD | 0 USD |
| Wednesday, March 1st, 2023 | CLACKSON TIMOTHY P | director, officer: President and CEO | 45,625 | A-Award | A | 45,625 | 0.00 USD | 0 USD |
| Friday, February 17th, 2023 | Shakespeare William | officer: See Remarks | 127,500 | A-Award | A | 127,500 | 11.42 USD | 1,456,050 USD |
| Friday, February 17th, 2023 | Rivera Victor | officer: Chief Scientific Officer | 97,500 | A-Award | A | 97,500 | 11.42 USD | 1,113,450 USD |
| Friday, February 17th, 2023 | Kerstein David | officer: Chief Medical Officer | 105,000 | A-Award | A | 105,000 | 11.42 USD | 1,199,100 USD |
| Friday, February 17th, 2023 | Dahms Bradford D. | officer: Chief Financial Officer | 105,000 | A-Award | A | 105,000 | 11.42 USD | 1,199,100 USD |
| Friday, February 17th, 2023 | CLACKSON TIMOTHY P | director, officer: President and CEO | 273,750 | A-Award | A | 273,750 | 11.42 USD | 3,126,225 USD |
| Thursday, December 29th, 2022 | Foresite Capital Management V, LLC | director | 3,585,346 | P-Purchase | A | 250,000 | 5.00 USD | 1,250,000 USD |
| Thursday, December 29th, 2022 | Foresite Capital Management V, LLC | director | 1,209,275 | P-Purchase | A | 250,000 | 5.00 USD | 1,250,000 USD |
| Friday, December 30th, 2022 | HAYDEN DONALD J JR | director | 10,000 | P-Purchase | A | 9,900 | 5.00 USD | 49,489 USD |
| Thursday, December 29th, 2022 | HAYDEN DONALD J JR | director | 100 | P-Purchase | A | 100 | 5.00 USD | 500 USD |
| Wednesday, November 30th, 2022 | Dahms Bradford D. | officer: Chief Financial Officer | 6,142.225 | P-Purchase | A | 1,502.189 | 6.66 USD | 10,000 USD |
| Friday, November 11th, 2022 | CLACKSON TIMOTHY P | officer: President and CEO | 351,030 | P-Purchase | A | 2,500 | 6.80 USD | 16,995 USD |
| Monday, November 7th, 2022 | GORDON CARL L | director | 16,734,518 | P-Purchase | A | 192,000 | 5.21 USD | 1,000,320 USD |
| Monday, November 7th, 2022 | ORBIMED ADVISORS LLC | director | 16,734,518 | P-Purchase | A | 192,000 | 5.21 USD | 1,000,320 USD |
| Monday, October 17th, 2022 | Stein Steven H | director | 60,000 | A-Award | A | 60,000 | 0.00 USD | 0 USD |
| Monday, October 17th, 2022 | Stein Steven H | None | 0 | None | None | USD | 0 USD | |
| Monday, October 17th, 2022 | Stein Steven H | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Friday, June 10th, 2022 | Yi Kathy | director: | 30,000 | A-Award | A | 30,000 | 0.00 USD | 0 USD |
| Friday, June 10th, 2022 | Dukes Iain D. | director, officer: Chairman | 30,000 | A-Award | A | 30,000 | 5.75 USD | 172,500 USD |
| Friday, June 10th, 2022 | Dukes Iain D. | director, officer: Chairman | 15,000 | A-Award | A | 15,000 | 5.75 USD | 86,250 USD |
| Friday, June 10th, 2022 | Dukes Iain D. | officer: Chairman | 15,000 | A-Award | A | 15,000 | 0.00 USD | 0 USD |
| Friday, June 10th, 2022 | GORDON CARL L | director: | 30,000 | A-Award | A | 30,000 | 0.00 USD | 0 USD |
| Friday, June 10th, 2022 | GORDON CARL L | director, 10 percent owner: | 30,000 | A-Award | A | 30,000 | 5.75 USD | 172,500 USD |
| Thursday, June 9th, 2022 | Foresite Capital Management V, LLC | director | 3,335,346 | I | 0 | 0.00 USD | 0 USD | |
| Thursday, June 9th, 2022 | Foresite Capital Management V, LLC | director | 959,275 | I | 0 | 0.00 USD | 0 USD | |
| Tuesday, May 17th, 2022 | HAYDEN DONALD J JR | director: | 60,000 | A-Award | A | 60,000 | 0.00 USD | 0 USD |
| Tuesday, May 17th, 2022 | HAYDEN DONALD J JR | director | 60,000 | A-Award | A | 60,000 | 8.02 USD | 481,200 USD |
| Tuesday, May 17th, 2022 | HAYDEN DONALD J JR | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Friday, February 18th, 2022 | Kerstein David | officer: Chief Medical Officer | 150,000 | A-Award | A | 150,000 | 11.21 USD | 1,681,500 USD |
| Friday, February 18th, 2022 | CLACKSON TIMOTHY P | director, officer: President and CEO | 450,000 | A-Award | A | 450,000 | 11.21 USD | 5,044,500 USD |
| Friday, February 18th, 2022 | Dalgarno David | officer: Chief Technical Officer | 130,000 | A-Award | A | 130,000 | 11.21 USD | 1,457,300 USD |
| Friday, February 18th, 2022 | Dahms Bradford D. | officer: Chief Financial Officer | 150,000 | A-Award | A | 150,000 | 11.21 USD | 1,681,500 USD |
| Friday, February 18th, 2022 | Shakespeare William | officer: See Remarks | 180,000 | A-Award | A | 180,000 | 11.21 USD | 2,017,800 USD |
| Friday, February 18th, 2022 | Rivera Victor | officer: Chief Scientific Officer | 130,000 | A-Award | A | 130,000 | 11.21 USD | 1,457,300 USD |
| Friday, January 21st, 2022 | GORDON CARL L | director, 10 percent owner: | 16,542,652 | P-Purchase | A | 111,896 | 9.97 USD | 1,115,603 USD |
| Thursday, January 20th, 2022 | GORDON CARL L | director, 10 percent owner: | 16,430,756 | P-Purchase | A | 35,000 | 9.95 USD | 348,250 USD |
| Wednesday, January 19th, 2022 | GORDON CARL L | director, 10 percent owner: | 16,395,756 | P-Purchase | A | 11,521 | 9.97 USD | 114,864 USD |
| Friday, January 21st, 2022 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 16,542,652 | P-Purchase | A | 111,896 | 9.97 USD | 1,115,603 USD |
| Thursday, January 20th, 2022 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 16,430,756 | P-Purchase | A | 35,000 | 9.95 USD | 348,250 USD |
| Wednesday, January 19th, 2022 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 16,395,756 | P-Purchase | A | 11,521 | 9.97 USD | 114,864 USD |
| Thursday, January 13th, 2022 | GORDON CARL L | director, 10 percent owner: | 16,384,235 | P-Purchase | A | 17,320 | 9.43 USD | 163,328 USD |
| Wednesday, January 12th, 2022 | GORDON CARL L | director, 10 percent owner: | 16,366,915 | P-Purchase | A | 18,897 | 10.06 USD | 190,104 USD |
| Tuesday, January 11th, 2022 | GORDON CARL L | director, 10 percent owner: | 16,348,018 | P-Purchase | A | 6,900 | 10.67 USD | 73,623 USD |
| Tuesday, January 11th, 2022 | GORDON CARL L | director, 10 percent owner: | 16,341,118 | P-Purchase | A | 1,600 | 9.81 USD | 15,696 USD |
| Thursday, January 13th, 2022 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 16,384,235 | P-Purchase | A | 17,320 | 9.43 USD | 163,328 USD |
| Wednesday, January 12th, 2022 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 16,366,915 | P-Purchase | A | 18,897 | 10.06 USD | 190,104 USD |
| Tuesday, January 11th, 2022 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 16,348,018 | P-Purchase | A | 6,900 | 10.67 USD | 73,623 USD |
| Tuesday, January 11th, 2022 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 16,341,118 | P-Purchase | A | 1,600 | 9.81 USD | 15,696 USD |
| Tuesday, December 21st, 2021 | CLACKSON TIMOTHY P | director, officer: President and CEO | 348,530 | P-Purchase | A | 2,600 | 9.76 USD | 25,381 USD |
| Tuesday, December 21st, 2021 | Dahms Bradford D. | officer: Chief Financial Officer | 1,970.036 | P-Purchase | A | 1,970.036 | 10.15 USD | 20,000 USD |
| Tuesday, October 12th, 2021 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 1,615,427 | C-Conversion | A | 1,615,427 | 0.00 USD | 0 USD |
| Tuesday, October 12th, 2021 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 0 | C-Conversion | D | 1,615,427 | 0.00 USD | 0 USD |
| Wednesday, October 6th, 2021 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 0 | I | 1,615,427 | 0.00 USD | 0 USD | |
| Tuesday, October 12th, 2021 | GORDON CARL L | director, 10 percent owner: | 16,339,518 | P-Purchase | A | 562,500 | 16.00 USD | 9,000,000 USD |
| Tuesday, October 12th, 2021 | GORDON CARL L | director, 10 percent owner: | 15,777,018 | C-Conversion | A | 15,777,018 | 0.00 USD | 0 USD |
| Tuesday, October 12th, 2021 | GORDON CARL L | director, 10 percent owner: | 499,150 | P-Purchase | A | 62,500 | 16.00 USD | 1,000,000 USD |
| Tuesday, October 12th, 2021 | GORDON CARL L | director, 10 percent owner: | 436,650 | C-Conversion | A | 436,650 | 0.00 USD | 0 USD |
| Tuesday, October 12th, 2021 | GORDON CARL L | director, 10 percent owner: | 0 | C-Conversion | D | 14,903,718 | 0.00 USD | 0 USD |
| Tuesday, October 12th, 2021 | GORDON CARL L | director, 10 percent owner: | 0 | C-Conversion | D | 436,650 | 0.00 USD | 0 USD |
| Tuesday, October 12th, 2021 | Shakespeare William | officer: See Remarks | 388,949 | P-Purchase | A | 625 | 16.00 USD | 10,000 USD |
| Tuesday, October 12th, 2021 | Rock Springs Capital Management LP | 10 percent owner | 599,320 | P-Purchase | A | 250,000 | 16.00 USD | 4,000,000 USD |
| Tuesday, October 12th, 2021 | Rock Springs Capital Management LP | 10 percent owner | 349,320 | C-Conversion | A | 349,320 | 0.00 USD | 0 USD |
| Tuesday, October 12th, 2021 | Rock Springs Capital Management LP | 10 percent owner | 87,329 | C-Conversion | A | 87,329 | 0.00 USD | 0 USD |
